Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LLY
LLY logo

LLY News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LLY News

Eli Lilly's Foundayo Prescription Growth Amidst Market Competition

23h agoseekingalpha

Novo Nordisk and Eli Lilly Compete Intensely as Oral Weight Loss Drug Market Emerges

4h agoFool

Eli Lilly and Novo Nordisk Compete in Weight Loss Drug Market

4h agoNASDAQ.COM

Lilly Launches Foundayo with Soft Market Reception Compared to Wegovy

14h agostocktwits

Eli Lilly's Foundayo Prescription Analysis

1d agoNewsfilter

Can Eli Lilly Reclaim a $1 Trillion Market Cap?

1d agoFool

Eli Lilly Aims to Reinstate Market Leadership Amid Competitive Landscape

1d agoNASDAQ.COM

Overview of This Week's Dividend Activities

1d agoseekingalpha

LLY Events

05/06 09:11
Eli Lilly Announces Additional $4.5B Investment in Lebanon
Eli Lilly and Company announced an additional $4.5B investment across two of its three Lebanon sites-bringing the company's total Indiana capital expansion commitments since 2020 to more than $21B. Lilly's evolving pipeline, as well as anticipated demand for its medicines, prompted this additional commitment. The investment will incorporate new process designs and technologies at Lilly Lebanon API, one of the company's future active pharmaceutical ingredient sites, as well as Lilly Lebanon Advanced Therapies, its first dedicated genetic medicine manufacturing facility opening today.
05/05 16:40
Major U.S. Averages Close Broadly Higher, Nasdaq Up 1.03%
The major averages closed broadly higher as oil pulled back, though the ceasefire between the U.S. and Iran continues to be fragile. However, U.S. Defense Secretary Pete Hegseth said the ceasefire "certainly holds" and claimed that two U.S. commercial ships have already "safely transited the strait, showing the lane is clear."Meanwhile, earnings remain strong and AI capital expenditures continue to act as a structural tailwind. There is persistent capital flow into semis and hyperscalers, with expectations for massive multi-year spend cycles anchoring estimates higher.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Palantirprovided areport for Q1PayPalreportedand provided its outlook for Q2 and FY26Coinbaseannounced plans to, or 700 employeesPfizerreportedand reiterated its FY26 guidancePinterestreportedand provided Q2 revenue guidance2. WALL STREET CALLS:Ulta Beautyto Buy at BofA on improved earnings flywheelRobloxto Neutral at Piper Sandler on lack of visibilityArgusChipotleto Buy, expects comp growth to accelerateStephensRepay Holdings, sees "two binary outcomes"Tractor Supplyto Neutral at Piper Sandler3. AROUND THE WEB:FDA officials have blocked publication of several studies supporting the safety of widely used vaccines against Covid-19 and shingles in recent months, NY Times reportsHondaplans to shelve its $11B Canada EV plant as demand sputters, Nikkei reportsNissanis planning to cut roughly 10% of its European workforce and consolidate production lines at its Sunderland Plant as part of a broader restructuring effort, while exploring partnerships such as with Chery to utilize excess capacity and improve financial performance, FT saysBerkshirehas selected Gen Re chairman Charlie Shamieh to succeed Ajit Jain, Vice Chairman of Insurance Operations, when Jain decides to retire, Bloomberg reportsAppleis planning to release a new "Create a Pass' feature for its next iPhone software update, which will allow users to build and customize their digital tickets and gift cards in the Wallet app, Bloomberg says4. MOVERS:Backblazehigher afterand raising its guidance for FY26EverQuote, Digital Oceanand BRC Inc.increase afterDigi Power Xgains after signing aGeneDxlower afterand lowered its guidance for FY26BellRing Brandsand Adtranfalls after5. EARNINGS/GUIDANCE:Portillo's, with EPS and revenue missing consensusIPG Photonicsand provided guidance for Q2, with CEO Mark Gitin commenting, "I am pleased to share that first-quarter revenue came in above our expectations"Neuroneticsand backed its guidance for FY26Surgery Partnersand backed its guidance for FY26, with CEO Eric Evans commenting, "We are encouraged by our solid start to 2026"Expeditors, with EPS and revenue beating consensusINDEXES:The Dow rose 356.35, or 0.73%, to 49,298.25, the Nasdaq gained 258.33, or 1.03%, to 25,326.13, and the S&P 500 advanced 58.47, or 0.81%, to 7,259.22.

LLY Monitor News

Eli Lilly's Q1 Earnings Report Preview Highlights Strong Drug Sales

Apr 30 2026

Eli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion

Apr 24 2026

Eli Lilly's Foundayo Receives FDA Approval for Obesity Treatment

Apr 01 2026

Eli Lilly's EBGLYSS Shows Positive Results in Pediatric Eczema Trial

Mar 17 2026

Eli Lilly Launches Zepbound® KwikPen® to Improve Obesity Treatment Access

Mar 05 2026

Eli Lilly's Zepbound KwikPen Receives FDA Approval for Obesity Treatment

Feb 23 2026

Eli Lilly's Strong Q4 2025 Results Amid Market Competition

Feb 05 2026

Eli Lilly Reports Strong Q4 2025 Results and 2026 Guidance

Feb 04 2026

LLY Earnings Analysis

Eli Lilly Q3 2025 Earnings: Revenue Growth & Strategic Gains- Intellectia AI™
6 months ago
Eli Lilly Q2 2025 Earnings: Record Growth & Future Prospects- Intellectia AI™
9 months ago
Eli Lilly's Triumph in Q4 2024 - Intellectia AI™
1 years ago
Eli Lilly and Company Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch